Skip to main content

Advertisement

Table 3 Odds ratios (OR) and 95% confidence interval (CI) for predicting G2-G3 ccRCC and stage II–III ccRCC

From: KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2

  Risk of G2-G3 ccRCC Risk of stage II–III ccRCC
OR 95% CI p OR 95% CI p
Age 0.994 0.926–1.068 0.875 1.054 0.998–1.113 0.062
p300t 1.076 1.029–1.126 0.001 1.003 0.973–1.034 0.851
H3AcK18 1.021 0.987–1.056 0.223 0.981 0.954–1.008 0.170
H3AcK14 0.971 0.943–0.999 0.041 0.975 0.953–0.999 0.041